Tango Therapeutics Inc (TNGX) Insider Trading
- $13,366,773.66
- $61,310,111.44
- March 25, 2026
- Rock Ventures Iv L.P. Third
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 25, 2026 | Insider | 12,000 | $20.11 | Sell | $241,320.00 | |
| Feb. 25, 2026 | Insider | 54,345 | $12.77 | Sell | $693,985.65 | |
| Feb. 3, 2026 | CFO | 10,317 | $12.26 | Sell | $126,486.42 | |
| Feb. 3, 2026 | Insider | 18,452 | $12.26 | Sell | $226,221.52 | |
| Feb. 3, 2026 | Director | 30,519 | $12.26 | Sell | $374,162.94 | |
| Sept. 16, 2025 | Major Shareholder | 363,541 | $7.04 | Sell | $2,559,328.64 | |
| Sept. 8, 2025 | Major Shareholder | 86,459 | $7.04 | Sell | $608,671.36 | |
| Sept. 5, 2025 | Major Shareholder | 642,906 | $7.00 | Sell | $4,500,342.00 | |
| Aug. 22, 2025 | Major Shareholder | 302,194 | $7.00 | Sell | $2,115,358.00 | |
| Aug. 19, 2025 | Major Shareholder | 1,100,000 | $7.01 | Sell | $7,711,000.00 | |
| Feb. 4, 2025 | Insider | 7,432 | $2.99 | Sell | $22,221.68 | |
| Feb. 4, 2025 | General Counsel | 2,774 | $2.99 | Sell | $8,294.26 | |
| Feb. 4, 2025 | CEO | 9,778 | $2.99 | Sell | $29,236.22 | |
| Feb. 4, 2025 | CFO | 4,284 | $2.99 | Sell | $12,809.16 | |
| Nov. 18, 2024 | Director | 10,000 | $3.78 | Buy | $37,800.00 | |
| Nov. 14, 2024 | Director | 10,000 | $3.62 | Buy | $36,200.00 | |
| Nov. 6, 2024 | Insider | 3,080,000 | $3.14 | Sell | $9,671,200.00 | |
| Oct. 25, 2024 | Insider | 633,000 | $6.87 | Sell | $4,348,710.00 | |
| Oct. 21, 2024 | Insider | 625,000 | $7.05 | Sell | $4,406,250.00 | |
| Sept. 13, 2024 | Major Shareholder | 67,400 | $10.53 | Sell | $709,722.00 | |
| Sept. 5, 2024 | Major Shareholder | 75,000 | $11.56 | Sell | $867,000.00 | |
| Aug. 30, 2024 | Major Shareholder | 175,000 | $11.60 | Sell | $2,030,000.00 | |
| Aug. 27, 2024 | Major Shareholder | 25,000 | $11.55 | Sell | $288,750.00 | |
| Aug. 19, 2024 | Major Shareholder | 150,000 | $10.09 | Sell | $1,513,500.00 | |
| Aug. 16, 2024 | Major Shareholder | 135,000 | $9.79 | Sell | $1,321,650.00 | |
| Aug. 1, 2024 | Major Shareholder | 40,000 | $9.80 | Sell | $392,000.00 | |
| July 30, 2024 | Insider | 95,000 | $9.70 | Buy | $921,500.00 | |
| July 24, 2024 | Major Shareholder | 200,000 | $9.82 | Sell | $1,964,000.00 | |
| July 22, 2024 | Major Shareholder | 262,740 | $9.78 | Sell | $2,569,597.20 | |
| July 17, 2024 | Major Shareholder | 550,171 | $9.79 | Sell | $5,386,174.09 | |
| July 1, 2024 | Insider | 110,731 | $8.87 | Sell | $982,183.97 | |
| June 28, 2024 | Insider | 29,000 | $8.57 | Sell | $248,530.00 | |
| June 6, 2024 | Insider | 63,000 | $7.24 | Sell | $456,120.00 | |
| May 3, 2024 | Insider | 60,000 | $7.61 | Sell | $456,600.00 | |
| May 1, 2024 | Insider | 75,000 | $7.43 | Sell | $557,250.00 | |
| Feb. 20, 2024 | Major Shareholder | 162,500 | $12.00 | Sell | $1,950,000.00 | |
| Feb. 7, 2024 | General Counsel | 1,354 | $12.62 | Sell | $17,087.48 | |
| Feb. 6, 2024 | Insider | 4,288 | $12.56 | Sell | $53,857.28 | |
| Feb. 6, 2024 | CEO | 4,681 | $12.56 | Sell | $58,793.36 | |
| Feb. 6, 2024 | CFO | 1,908 | $12.56 | Sell | $23,964.48 | |
| Nov. 1, 2023 | Insider | 7,507 | $8.39 | Sell | $62,983.73 | |
| Oct. 16, 2023 | Insider | 500,000 | $6.84 | Buy | $3,420,000.00 | |
| Oct. 13, 2023 | Insider | 750,000 | $7.07 | Buy | $5,302,500.00 | |
| Oct. 9, 2023 | Insider | 175,000 | $9.97 | Sell | $1,744,750.00 | |
| Aug. 11, 2023 | Insider | 475,000 | $5.15 | Buy | $2,446,250.00 | |
| Oct. 13, 2022 | Major Shareholder | 70,000 | $4.65 | Buy | $325,500.00 | |
| Oct. 11, 2022 | Major Shareholder | 117,000 | $4.25 | Buy | $497,250.00 | |
| Oct. 6, 2022 | Major Shareholder | 70,394 | $4.06 | Buy | $285,799.64 | |
| Oct. 4, 2022 | Major Shareholder | 25,606 | $3.67 | Buy | $93,974.02 |
Insiders are both buying and selling Tango Therapeutics Inc stock.
The insider traders at Tango Therapeutics Inc are: Rock Ventures Iv L.P. Third, Boxer Capital, Llc, Adam Crystal, Mva Investors, Llc, Boxer Capital Management, Llc, Daniella Beckman, Barbara Weber, Douglas Barry, and Mace Rothenberg
The most active insider trader at Tango Therapeutics Inc is Rock Ventures Iv L.P. Third with 17 trades.
Rock Ventures Iv L.P. Third has sold the most Tango Therapeutics Inc stock with a total value of $39,046,421.93.
Boxer Capital, Llc has bought the most Tango Therapeutics Inc stock with a total value of $15,791,273.66.
The most recent insider trade for Tango Therapeutics Inc was on March 25, 2026.
The single biggest insider buy for Tango Therapeutics Inc was from Boxer Capital, Llc with a total value of $5,302,500.00 on Oct. 13, 2023.
The single biggest insider sell for Tango Therapeutics Inc was from Boxer Capital Management, Llc with a total value of $9,671,200.00 on Nov. 6, 2024.
